In the last trading session, 1.07 million Evolent Health Inc (NYSE:EVH) shares changed hands as the company’s beta touched 1.19. With the company’s per share price at $10.14 changed hands at $0.15 or 1.50% during last session, the market valuation stood at $1.18B. EVH’s last price was a discount, traded about -231.66% off its 52-week high of $33.63. The share price had its 52-week low at $8.35, which suggests the last value was 17.65% up since then. When we look at Evolent Health Inc’s average trading volume, we note the 10-day average is 3.0 million shares, with the 3-month average coming to 2.54 million.
Analysts gave the Evolent Health Inc (EVH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.13. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended EVH as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Evolent Health Inc’s EPS for the current quarter is expected to be 0.09.
Evolent Health Inc (NYSE:EVH) trade information
Instantly EVH was in green as seen at the end of in last trading. With action 7.99%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -9.87%, with the 5-day performance at 7.99% in the green. However, in the 30-day time frame, Evolent Health Inc (NYSE:EVH) is 1.20% up. Looking at the short shares, we see there were 14.2 million shares sold at short interest cover period of 5.68 days.
The consensus price target for the stock as assigned by Wall Street analysts is 19, meaning bulls need an upside of 46.63% from its current market value. According to analyst projections, EVH’s forecast low is 14 with 38 as the target high. To hit the forecast high, the stock’s price needs a -274.75% plunge from its current level, while the stock would need to soar -38.07% for it to hit the projected low.
Evolent Health Inc (EVH) estimates and forecasts
Year-over-year growth is forecast to reach -19.00% down from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of 460.15M. 14 analysts are of the opinion that Evolent Health Inc’s revenue for the current quarter will be 503.6M. The company’s revenue for the corresponding quarters a year ago was 639.65M and 647.14M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -28.06%. The estimates for the next quarter sales put growth at -22.18%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 25.98%. The 2025 estimates are for Evolent Health Inc earnings to increase by 4.08%, but the outlook for the next 5-year period is at 28.63% per year.
EVH Dividends
Evolent Health Inc is expected to release its next quarterly earnings report on 2025-Feb-19.
Evolent Health Inc (NYSE:EVH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.71% of Evolent Health Inc shares while 107.32% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 110.32%. There are 107.32% institutions holding the Evolent Health Inc stock share, with WELLINGTON MANAGEMENT GROUP LLP the top institutional holder. As of 2024-06-30, the company held 9.7383% of the shares, roughly 11.17 million EVH shares worth $213.55 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.6862% or 11.06 million shares worth $211.39 million as of 2024-06-30.
Among Mutual Funds, the top two as of Oct 31, 2024 were Vanguard Specialized-Health Care Fund and Fidelity Small Cap Value Fund . With 4.98 shares estimated at $50.46 million under it, the former controlled 4.27% of total outstanding shares. On the other hand, Fidelity Small Cap Value Fund held about 3.83% of the shares, roughly 4.47 shares worth around $45.32 million.
